Abstract

BackgroundGenome-wide association studies (GWAS) have emerged as a powerful approach for identifying susceptibility loci associated with polygenetic diseases such as type 2 diabetes mellitus (T2DM). However, it is still a daunting task to prioritize single nucleotide polymorphisms (SNPs) from GWAS for further replication in different population. Several recent studies have shown that genetic variation often affects gene-expression at proximal (cis) as well as distal (trans) genomic locations by different mechanisms such as altering rate of transcription or splicing or transcript stability.MethodsTo prioritize SNPs from GWAS, we combined results from two GWAS related to T2DM, the Diabetes Genetics Initiative (DGI) and the Wellcome Trust Case Control Consortium (WTCCC), with genome-wide expression data from pancreas, adipose tissue, liver and skeletal muscle of individuals with or without T2DM or animal models thereof to identify T2DM susceptibility loci.ResultsWe identified 1,170 SNPs associated with T2DM with P < 0.05 in both GWAS and 243 genes that were located in the vicinity of these SNPs. Out of these 243 genes, we identified 115 differentially expressed in publicly available gene expression profiling data. Notably five of them, IGF2BP2, KCNJ11, NOTCH2, TCF7L2 and TSPAN8, have subsequently been shown to be associated with T2DM in different populations. To provide further validation of our approach, we reversed the approach and started with 26 known SNPs associated with T2DM and related traits. We could show that 12 (57%) (HHEX, HNF1B, IGF2BP2, IRS1, KCNJ11, KCNQ1, NOTCH2, PPARG, TCF7L2, THADA, TSPAN8 and WFS1) out of 21 genes located in vicinity of these SNPs were showing aberrant expression in T2DM from the gene expression profiling studies.ConclusionsUtilizing of gene expression profiling data from different tissues of individuals with or without T2DM or animal models thereof is a powerful tool for prioritizing SNPs from WGAS for further replication studies.

Highlights

  • Genome-wide association studies (GWAS) have emerged as a powerful approach for identifying susceptibility loci associated with polygenetic diseases such as type 2 diabetes mellitus (T2DM)

  • Diabetes Genetics Initiative (DGI) The DGI included 1,464 T2DM patients and 1,467 normoglycemic controls from Sweden and Finland [2]. These samples were genotyped on the Affymetrix GeneChip® Human Mapping 500K Array Set which contains ~500,000 single nucleotide polymorphisms (SNPs) for interrogation. 386,731 autosomal SNPs were included for further analyses which have genotype call frequency > 0.95, the Hardy-Weinberg equilibrium (HWE) P > 10-6 in controls and a minor allele frequency (MAF) > 0.01 in both populations

  • We selected 1,170 directly genotyped SNPs associated with T2DM with P < 0.05 in both GWAS (Table 1) and 243 genes were located in the vicinity of these SNPs (Table 2)

Read more

Summary

Introduction

Genome-wide association studies (GWAS) have emerged as a powerful approach for identifying susceptibility loci associated with polygenetic diseases such as type 2 diabetes mellitus (T2DM). It is still a daunting task to prioritize single nucleotide polymorphisms (SNPs) from GWAS for further replication in different population. Several recent studies have shown that genetic variation often affects gene-expression at proximal (cis) as well as distal (trans) genomic locations by different mechanisms such as altering rate of transcription or splicing or transcript stability. Genome-wide association study (GWAS) offers unbiased ways to examine association of more than a million single nucleotide polymorphisms (SNPs) with disease [1]. Genetic variation often influences gene expression by different mechanisms such as altering rate of transcription or splicing or transcript stability [9]. To provide further validation of our approach, we reversed the approach and tested 21 genes (ADAMTS9, CDKAL1, CDKN2B, FTO, GCK, GCKR, HHEX, HNF1B, IGF2BP2, IRS1, JAZF1, KCNJ11, KCNQ1, MTNR1B, NOTCH2, PPARG, SLC30A8, TCF7L2, THADA, TSPAN8 and WFS1) located in vicinity of 26 known SNPs associated with T2DM and related traits [2,5,6,10,11,12,13] for their expression in the same data sets

Objectives
Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.